Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Chiang Mai University | OTHER |
| Prince Songkla University | UNKNOWN |
| Chulalongkorn University | OTHER |
| Siriraj Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Extracorporeal shock wave lithotripsy (ESWL) and Percutaneous nephrolithotomy (PCNL) become the therapy of choice for renal stone. Although providing good results, stone recurrence is usually found as the therapies do not change the underlying metabolic abnormality. Among the metabolic disorders, hypocitraturia is an important risk factor for calcium nephrolithiasis. This study evaluate the preventive effects of potassium sodium citrate on stone recurrence as well as stone growth post ESWL or PCNL, in patients with calcium-containing stones.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Potassium-sodium citrate | Drug | The treated group was given oral potassium-sodium citrate 81 mEq/day The control group received no treatment |
|
| Measure | Description | Time Frame |
|---|---|---|
| rate of stone recurrence or stone growth | The patients were evaluated at 6 months after the initial treatment for serum chemistry and urinalysis. After 12 months, all patients were evaluated for serum chemistry, urinalysis, 24-hour urine study and plain KUB. | 12 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bannakij Lojanapiwat, MD | Division of Urology, Department of Surgery, Chiangmai University, Thailand | Principal Investigator |
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Apr 11, 2011 | |
| Reset | May 9, 2011 | |
| Release | May 26, 2011 |
Not provided
| OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
| Reset | Jun 23, 2011 |
| Release | Jul 11, 2012 |
| Reset | Aug 16, 2012 |
| Release | Aug 16, 2012 |
| Reset | Sep 12, 2012 |
| Release | Sep 12, 2012 |
| Reset | Oct 11, 2012 |
| Release | May 7, 2013 |
| Reset | Jun 10, 2013 |
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Apr 11, 2011 | May 9, 2011 | |||
| May 26, 2011 | Jun 23, 2011 | |||
| Jul 11, 2012 | Aug 16, 2012 | |||
| Aug 16, 2012 | Sep 12, 2012 | |||
| Sep 12, 2012 | Oct 11, 2012 | |||
| May 7, 2013 | Jun 10, 2013 |
| ID | Term |
|---|---|
| D007669 | Kidney Calculi |
| ID | Term |
|---|---|
| D053040 | Nephrolithiasis |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052878 | Urolithiasis |
| D014545 | Urinary Calculi |
| D052801 | Male Urogenital Diseases |
| D002137 | Calculi |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| C008309 | magnesium citrate, potassium citrate, pyridoxine HCl, sodium citrate drug combination |
| D002951 | Citrates |
| ID | Term |
|---|---|
| D014233 | Tricarboxylic Acids |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
Not provided
Not provided